IO Biotech, Inc. (IOBTQ) Operating Leases (2022 - 2025)
IO Biotech's (IOBTQ) quarterly Operating Leases came in at $700000.0 in Q3 2025, down 46.15% YoY from $1.3 million in Q3 2024, and down 22.22% on a QoQ basis from $900000.0 in Q2 2025.
IO Biotech, Inc. (IOBTQ) Operating Leases (2022 - 2025) Analysis & Trends
IO Biotech (IOBTQ) has 4 years of Operating Leases data on file, last reported at $700000.0 in Q3 2025.
- Quarterly Operating Leases fell 46.15% year-over-year to $700000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $700000.0 (down 46.15% YoY) and the FY2024 annual result came in at $1.2 million, down 34.86% from the prior year.
- Operating Leases retreated to $700000.0 in Q3 2025, from $900000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.3 million in Q1 2023 to a low of $700000.0 in Q3 2025.
- A 4-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases decreased 19.16% — and 2025, when it tumbled 46.15%.
- Tracing IOBTQ's Operating Leases over 4 years: stood at $2.3 million in 2022, then declined by 19.16% to $1.8 million in 2023, then tumbled by 34.86% to $1.2 million in 2024, then tumbled by 41.57% to $700000.0 in 2025.
- The last three Operating Leases figures came in at $700000.0 (Q3 2025), $900000.0 (Q2 2025), and $1.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.28 Mn |